DK128077B - Analogifremgangsmåde til fremstilling af substituerede phenyleddikesyrer eller de tilsvarende optisk aktive forbindelser eller salte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af substituerede phenyleddikesyrer eller de tilsvarende optisk aktive forbindelser eller salte deraf.

Info

Publication number
DK128077B
DK128077B DK121471AA DK121471A DK128077B DK 128077 B DK128077 B DK 128077B DK 121471A A DK121471A A DK 121471AA DK 121471 A DK121471 A DK 121471A DK 128077 B DK128077 B DK 128077B
Authority
DK
Denmark
Prior art keywords
salts
preparation
optically active
active compounds
analogous process
Prior art date
Application number
DK121471AA
Other languages
Danish (da)
English (en)
Inventor
J Borck
J Dahm
J Kraemer
A Wild
J Hovy
E Schorscher
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of DK128077B publication Critical patent/DK128077B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK121471AA 1970-03-20 1971-03-15 Analogifremgangsmåde til fremstilling af substituerede phenyleddikesyrer eller de tilsvarende optisk aktive forbindelser eller salte deraf. DK128077B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702013376 DE2013376A1 (de) 1970-03-20 1970-03-20 Substituierte Phenylessigsauren und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
DK128077B true DK128077B (da) 1974-02-25

Family

ID=5765732

Family Applications (1)

Application Number Title Priority Date Filing Date
DK121471AA DK128077B (da) 1970-03-20 1971-03-15 Analogifremgangsmåde til fremstilling af substituerede phenyleddikesyrer eller de tilsvarende optisk aktive forbindelser eller salte deraf.

Country Status (15)

Country Link
AT (1) AT310728B (enrdf_load_stackoverflow)
BE (1) BE764546A (enrdf_load_stackoverflow)
CA (1) CA973884A (enrdf_load_stackoverflow)
CH (1) CH556834A (enrdf_load_stackoverflow)
CS (1) CS160138B2 (enrdf_load_stackoverflow)
DE (1) DE2013376A1 (enrdf_load_stackoverflow)
DK (1) DK128077B (enrdf_load_stackoverflow)
ES (1) ES389399A1 (enrdf_load_stackoverflow)
FR (1) FR2085723B1 (enrdf_load_stackoverflow)
GB (1) GB1304502A (enrdf_load_stackoverflow)
IL (1) IL36044A (enrdf_load_stackoverflow)
NL (1) NL7102257A (enrdf_load_stackoverflow)
PL (1) PL72098B1 (enrdf_load_stackoverflow)
SE (1) SE372265B (enrdf_load_stackoverflow)
ZA (1) ZA71329B (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2114420A1 (de) * 1971-03-25 1972-10-05 Merck Patent Gmbh, 6100 Darmstadt Substituierte Phenylalkanol-Derivate und Verfahren zu ihrer Herstellung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795036A1 (de) * 1968-08-01 1972-01-20 Merck Patent Gmbh p-Aminoarylalkanol-Derivate und Verfahren zu ihrer Herstellung
CH559755A5 (enrdf_load_stackoverflow) * 1968-03-27 1975-03-14 Ciba Geigy Ag

Also Published As

Publication number Publication date
FR2085723B1 (enrdf_load_stackoverflow) 1974-08-23
GB1304502A (enrdf_load_stackoverflow) 1973-01-24
BE764546A (fr) 1971-09-20
IL36044A (en) 1975-05-22
DE2013376A1 (de) 1971-10-07
AT310728B (de) 1973-10-10
IL36044A0 (en) 1971-03-24
NL7102257A (enrdf_load_stackoverflow) 1971-09-22
SE372265B (enrdf_load_stackoverflow) 1974-12-16
CH556834A (de) 1974-12-13
CA973884A (en) 1975-09-02
CS160138B2 (enrdf_load_stackoverflow) 1975-02-28
FR2085723A1 (enrdf_load_stackoverflow) 1971-12-31
ZA71329B (en) 1971-10-27
PL72098B1 (enrdf_load_stackoverflow) 1974-06-29
ES389399A1 (es) 1974-03-16

Similar Documents

Publication Publication Date Title
DK138602B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive penicilliner eller salte deraf.
DK125021B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-4-phenyl-isoquinolinderivater eller syreadditionssalte deraf eller de tilsvarende optisk aktive forbindelser.
DK140281B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.
DK136527B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive p-alkoxyfenoxypropanolaminer eller syreadditionssalte deraf.
DK136217B (da) Fremgangsmåde til fremstilling af 7-acylamidocephem-4-karboxylsyrer eller 6-acylamidopenicillansyrer eller salte eller estere af sådanne forbindelser.
DK138074B (da) Analogifremgangsmåde til fremstilling af substituerede phenyleddikesyrer eller estere eller optisk aktive forbindelser eller salte deraf.
DK117639B (da) Fremgangsmåde til fremstilling af substituerede phenyleddikesyrer eller salte deraf.
DK125461B (da) Fremgangsmåde til fremstilling af substituerede phenyleddikesyrer eller salte deraf.
DK129162B (da) Analogifremgangsmåde til fremstilling af 4-oxo-4H-1-benzopyran-2-carboxylsyrer eller salte, estere eller amider deraf.
DK139575B (da) Analogifremgangsmåde til fremstilling af 2-aminomethylen-1-indanon-forbindelser eller syreadditionssalte deraf.
DK138020B (da) Analogifremgangsmåde til fremstilling af pyrazolodiazepinforbindelser eller salte deraf.
DK138599B (da) Analogifremgangsmåde til fremstilling af sulfamylantranilsyrer eller salte eller estre deraf.
DK123708B (da) Fremgangsmåde til fremstilling af polyencarboxylsyrer eller salte deraf.
DK138491B (da) Analogifremgangsmåde til fremstilling af N-(1-cyclohexyl-3-pyrrolidinyl)-benzamider eller syreadditionssalte deraf.
DK139582B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf.
DK120709B (da) Analogifremgangsmåde til fremstilling af substituerede hydroxyfenyl-alkylaminer eller optisk aktive antipoder eller salte deraf.
DK140639B (da) Fremgangsmåde til fremstilling af 7beta-acylamino-3-methyl-ceph-3-em-4-carboxylsyrer eller salte, estere eller amider heraf.
DK138943B (da) Analogifremgangsmåde til fremstilling af substituerede dibenzocyclohepten-carboxamider eller syreadditionssalte deraf.
DK137758B (da) Analogifremgangsmåde til fremstilling af 2-(5-nitro-2-imidazolyl)-benzimidazoler eller salte deraf.
DK134548B (da) Analogifremgangsmåde til fremstilling af sulfamyl-m-aminobenzoesyrer eller salte, estre eller amider deraf.
DK138988B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive morphinanderivater.
DK131149B (da) Analogifremgangsmåde til fremstilling af 4-hydroxy-cinnolincarboxylsyrer eller salte deraf.
DK134014B (da) Analogifremgangsmåde til fremstilling af cycloalkyllactamimider eller syreadditionssalte deraf.
DK129718B (da) Analogifremgangsmåde til fremstilling af tiazolino-pyrimidin-5-oner eller deres syreadditionssalte eller de tilsvarende optisk aktive forbindelser.
DK127059B (da) Analogifremgangsmåde til fremstilling af substituerede 1-phenoxy-2-hydroxy-3-tert.butylaminopropaner eller salte heraf eller de tilsvarende optisk aktive antipoder.